Product information
From Health Canada
Current status:
Marketed
Current status date:
2022-08-16
Original market date: See footnote 1
2022-08-16
Product name:
HYPERHEP B
Description:
PREFILLED SYRINGE (NEONATAL)
DIN:
02520125 Electronic product monograph is not available
Company:
GRIFOLS THERAPEUTICS LLC
8368 Us 70 Business Hwy. West
Clayton
North Carolina
United States
27520-9464
Class:
Human
Dosage form(s):
Solution
Route(s) of administration:
Intramuscular
Number of active ingredient(s):
1
Schedule(s):
Schedule D
American Hospital Formulary Service (AHFS): See footnote 3
80:04.00
Anatomical Therapeutic Chemical (ATC): See footnote 4
J06BB04 HEPATITIS B IMMUNOGLOBULIN
Active ingredient group (AIG) number:See footnote5
0114080002
Active ingredient(s) | Strength |
---|---|
HEPATITIS B IMMUNOGLOBULIN (HUMAN) | 110 UNIT / 0.5 ML |